[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"temperature-monitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:temperature-monitoring":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100651280","continuous-monitoring-of-body-temperature-in-mothers-and-their-preterm-neonates-100651280",false,"NCT07758205","Continuous Monitoring of Body Temperature in Mothers and Their Preterm Neonates","Continuous Monitoring of Body Temperature in Mothers and Their Preterm Neonates During the Immediate Postnatal Transition - A Prospective Observational Pilot Study","MonT NeoP","Inclusion Criteria:\n\n* Preterm neonates born between 32+0 and 36+6 weeks of gestation.\n* Written informed consent obtained from the mother (or legally authorized representative, where applicable according to national legislation) before delivery and before any study-specific procedures are performed.\n\nExclusion Criteria:\n\n* Gestational age \\\u003C32+0 weeks or ≥37+0 weeks.\n* No decision to conduct full life support.\n* Written informed consent not obtained before delivery.\n* Congenital malformation.","ALL",{"count":19,"type":20},40,"ESTIMATED","OBSERVATIONAL","Preterm babies are at increased risk of becoming too cold or too warm immediately after birth because they have an immature ability to regulate their body temperature. Maintaining a normal body temperature during the first minutes after birth is important because both low and high body temperatures are associated with an increased risk of complications. Current temperature monitoring is performed intermittently using conventional thermometers and does not provide continuous information about changes in body temperature.\n\nThis prospective observational pilot study aims to evaluate the feasibility of using the SteadyTemp® adhesive thermometer, a wireless, non-invasive temperature sensor, for continuous body temperature monitoring in preterm neonates (32+0 to 36+6 weeks of gestation) during the first 15 minutes after birth. The study will also compare temperatures recorded by the adhesive thermometer with a routine rectal temperature measurement and assess skin tolerability after removal of the adhesive patch. In addition, maternal body temperature will be continuously monitored during delivery to explore the relationship between maternal intrapartum temperature and neonatal temperature during the immediate postnatal transition.\n\nThe study hypothesizes that continuous temperature monitoring with the SteadyTemp® adhesive thermometer is feasible in preterm neonates, that the recorded temperatures agree with standard rectal temperature measurements, that the device is well tolerated without clinically relevant skin irritation, and that maternal intrapartum temperature correlates with neonatal body temperature during the immediate postnatal transition. The results of this pilot study will provide preliminary evidence to support future studies evaluating continuous, non-invasive temperature monitoring as a tool to improve thermal management of preterm neonates immediately after birth.",[24,25],"Preterm Neonate","Temperature Monitoring",[27,28],"postnatal temperature","preterm neonate","NOT_YET_RECRUITING","2026-08-12",{"date":32,"type":33},"2026-08-14","ACTUAL",{"date":35,"type":20},"2026-08-15",{"date":37,"type":20},"2028-08-15",{"name":39,"class":40},"Medical University of Graz","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":57,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":41},"100631954","non-invasive-temperature-monitoring-in-pediatric-intensive-care-patients-requiring-targeted-temperature-management-evaluation-of-temple-touch-pro-100631954","NCT07507396","Non-invasive Temperature Monitoring in Pediatric Intensive Care Patients Requiring Targeted Temperature Management: Evaluation of Temple Touch Pro","Inclusion Criteria:\n\n1. Age 0 to less than 18 years of age\n2. PICU Diagnosis requiring targeted temperature management. For example traumatic brain injury, cardiac arrest, or anoxic brain injury\n3. Requires continuous temperature monitoring with a foley catheter (bladder) or a general purpose probe placed in the esophagus.\n4. Enrolled within 24 hours of start of continuous temperature monitoring.\n5. Patient has adequate forehead space to accommodate the TTP sensor\n6. Temporal artery perfusion not compromised by injury or other pathology\n7. No surgical procedure planned for 72 hours\n8. Targeted temperature management expected for at least 24 hours at time of consent\n\nExclusion Criteria:\n\n1. Already enrolled in another trial addressing temperature management\n2. Allergy to medical grade acrylic adhesive\n3. Patient does not tolerate placement of TTP sensor on forehead\n4. Contraindication to the placement of two or more of Foley, esophageal, and rectal temperature probes.\n5. A history of skin irritation, skin sensitivity, or skin disease, including psoriasis, eczema, atopic dermatitis, and skin cancer.\n6. Pregnant or lactating female","0 Years","17 Years",{"count":51,"type":20},20,"INTERVENTIONAL",[54],"NA","The purpose of this study is to evaluate the Temple Touch Pro (TTP) in Pediatric Intensive Care Unity (PICU) patients requiring targeted temperature control.",[25],[58,59,60,61,62,63],"temperature monitoring","Temple Touch Pro","esophageal","rectum","bladder","temporal artery","2026-03-27",{"date":66,"type":33},"2026-04-02",{"date":68,"type":20},"2026-05",{"date":70,"type":20},"2027-05",{"name":72,"class":40},"Medical College of Wisconsin",{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":17,"minAge":81,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":84,"conditions":85,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":4},"100623471","clinical-accuracy-validation-of-the-moni-patc-temperature-monitoring-patch-during-surgery-compared-with-esophageal-and-bladder-temperature-100623471","NCT07397065","Clinical Accuracy Validation of the Moni-Patc Temperature Monitoring Patch During Surgery (Compared With Esophageal and Bladder Temperature)","Moni-Patc Temperature Monitoring Patch System Clinical Accuracy Validation","Moni-Patch OR","Inclusion Criteria:\n\n1. Age ≥18 years\n2. Subject is undergoing an elective surgical procedure expected to require at least 60min of general anesthesia and during which routine esophageal (Teso) and bladder (Tbld) temperature monitoring is expected.\n3. Subjects are expected to remain hospitalized at least overnight after surgery.\n4. Subject specifically agrees to temperature Sensor placement on the neck prior to surgery.\n5. Must be able to attach the Sensor away from the operative field (neck) with uninterrupted wireless connection between the Sensor and the Receiver (as close as possible).\n6. Use environment must meet both of the following parameters:\n\n   1. Temperature 15-40⁰ C\u002F59-104⁰ F\n   2. Humidity 30-75% RH (non-condensing)\n7. For non-English speaking subjects, a translator must be present at the time of consent.\n\nExclusion Criteria:\n\n1. Subjects unable to provide their own consent. Consent from family or LOR is not acceptable.\n2. Subjects undergoing surgical procedures who have conditions of the esophagus or bladder that contraindicate placement of these monitoring probes\u002Fsensor.\n3. Subjects whose surgery does not involve the monitoring of esophageal or bladder temperature.\n4. Subjects undergoing surgery that prohibits placement of an esophageal temperature monitoring probe\u002Fsensor (e.g. neck surgery).\n5. Subjects with medical conditions such as inflammation, scratches, redness, rash at the Sensor placement site.\n6. Subjects for whom the sensor cannot be securely adhered to the skin without floating or detaching, or accurately positioned over the carotid artery.\n7. Not for use in MRI or CT facilities.\n8. Use environment does not meet one or more parameters.","18 Years",{"count":83,"type":20},30,"Moni-Patc Temperature Monitoring Patch System, a non-invasive, continuous temperature monitoring device designed to estimate core body temperature by applying a Sensor to the neck.This clinical accuracy validation study aims to verify the accuracy and repeatability of the Moni-Patch compared with an FDA-cleared continuous esophageal and bladder temperature monitoring device used as the clinical reference.Main ObjectivesTo verify that the Moni-Patch and the reference device(esophageal and bladder) demonstrate acceptable agreement, as defined by Bland-Altman Analyses (bias within ±0.4°C and limits of agreement between -1.0°C and 1.0°C).To verify the consistency and repeatability of temperature measurements obtained from the Moni-Patch during continuous monitoring.",[25,86],"Intraoperative","2026-02-05",{"date":89,"type":33},"2026-02-09",{"date":91,"type":20},"2026-02-06",{"date":93,"type":20},"2026-06-30",{"name":95,"class":96},"Murata Vios, Inc.","INDUSTRY"]